David Malek

David Malek

Plus aucun poste en cours

Fortune : 20 M $ au 30/09/2026

48 ans
Health Technology
Finance
Consumer Services

Profil

David Malek currently works at Nan Fung Life Sciences, as Investment Director from 2020, Braveheart Bio, Inc., as Director from 2025, and Pivotal Bioventure Partners Investment Advisor LLC, as Venture Partner from 2022.
Mr. Malek also formerly worked at Sanofi-Aventis U.S.
LLC, as Oncology Director-New Products from 2006 to 2011, Avalyn Pharma, Inc., as Director, Israel Advanced Technology Industries, as Board Member from 2015 to 2019, Pivotal Bioventure Partners China Advisor (Beijing) Co. Ltd., as Operating Partner from 2018 to 2021, Arctic Vision (Shanghai) Biotechnology Co., Ltd., as Chief Business Officer from 2019 to 2020, BioLineRx Ltd., as Chief Business Officer from 2011 to 2018, and Oncxerna Therapeutics, Inc., as Chief Business Officer from 2017 to 2021.
Mr. Malek received his Masters Business Admin degree from Tuck School of Business at Dartmouth and undergraduate degree from the University of Haifa.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
1,13%
07/08/2026 1 013 297 ( 1,13% ) 20 M $ 30/09/2026

Postes actifs de David Malek

SociétésPosteDébut
Private Equity Investor 01/11/2020
Private Equity Investor -

Anciens postes connus de David Malek

SociétésPosteFin
Corporate Officer/Principal 01/12/2021
Private Equity Investor 01/03/2021
Corporate Officer/Principal 01/10/2020
Private Equity Investor 01/09/2019
BIOLINERX LTD. Corporate Officer/Principal 01/03/2018
Voir l'expérience en détail de David Malek

Formation de David Malek

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

74

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Finance

Finance

Finance

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. David Malek